Aceragen

YTD

ALL

Why Robinhood?

You can watch Aceragen and buy or sell other stocks, ETFs, and their options commission-free!

About ACGN

Aceragen, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the research and development of medications for rare and orphan diseases.

CEO

John Clayton Taylor

CEOJohn Clayton Taylor

Employees

—

Employees—

Headquarters

Research Triangle Park, North Carolina

HeadquartersResearch Triangle Park, North Carolina

Founded

1989

Founded1989

Employees

—

Employees—

ACGN Key Statistics

Market cap

3.20M

Market cap3.20M

Price-Earnings ratio

-0.07

Price-Earnings ratio-0.07

Dividend yield

—

Dividend yield—

Average volume

44.14K

Average volume44.14K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.00

52 Week high$16.00

52 Week low

$0.3601

52 Week low$0.3601

People also own

Based on the portfolios of people who own ACGN. This list is generated using Robinhood data, and it’s not a recommendation.

SNDL

Cenntro Electric Group Li…